Lexaria Bioscience Corp. (LEXX)
3.51
-0.46
(-11.59%)
USD |
NASDAQ |
Sep 14, 16:00
3.51
0.00 (0.00%)
After-Hours: 16:31
Lexaria Bioscience Price : 3.51 for Sept. 14, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 11, 2026 | 4.15 | 4.72 | 3.645 | 3.97 | 197057.0 |
| Sep 10, 2026 | 7.00 | 7.50 | 4.04 | 4.05 | 226220.0 |
| Sep 09, 2026 | 9.44 | 9.52 | 6.405 | 6.60 | 74405.00 |
| Sep 08, 2026 | 11.09 | 11.09 | 8.81 | 9.37 | 122227.0 |
| Sep 04, 2026 | 12.26 | 14.37 | 12.26 | 14.15 | 22428.00 |
| Sep 03, 2026 | 13.33 | 13.93 | 12.25 | 12.32 | 74765.00 |
| Sep 02, 2026 | 12.63 | 13.61 | 12.40 | 13.20 | 40951.00 |
| Sep 01, 2026 | 11.13 | 12.89 | 11.13 | 12.48 | 65451.00 |
| Aug 31, 2026 | 10.30 | 12.20 | 10.30 | 11.28 | 359550.0 |
| Aug 28, 2026 | 11.42 | 12.48 | 10.35 | 10.35 | 61908.00 |
| Aug 27, 2026 | 10.97 | 11.78 | 10.24 | 11.68 | 505648.0 |
| Aug 26, 2026 | 11.70 | 11.90 | 11.00 | 11.04 | 5232.00 |
| Aug 25, 2026 | 10.75 | 11.60 | 10.60 | 11.60 | 12330.00 |
| Aug 24, 2026 | 10.96 | 11.10 | 10.41 | 10.54 | 14940.00 |
| Aug 21, 2026 | 11.38 | 11.53 | 10.80 | 10.92 | 8919.00 |
| Aug 20, 2026 | 11.96 | 12.89 | 11.24 | 11.27 | 67113.00 |
| Aug 19, 2026 | 11.93 | 11.98 | 11.06 | 11.51 | 130171.0 |
| Aug 18, 2026 | 10.18 | 12.12 | 10.18 | 11.52 | 32288.00 |
| Aug 17, 2026 | 9.31 | 10.46 | 8.74 | 10.32 | 35111.00 |
| Aug 14, 2026 | 7.99 | 9.18 | 7.975 | 9.04 | 15760.00 |
| Aug 13, 2026 | 6.08 | 8.26 | 5.95 | 8.10 | 94061.00 |
| Aug 12, 2026 | 5.75 | 6.15 | 5.60 | 6.12 | 14983.00 |
| Aug 11, 2026 | 5.50 | 5.990 | 5.50 | 5.79 | 8775.00 |
| Aug 10, 2026 | 5.27 | 5.49 | 5.27 | 5.49 | 9562.00 |
| Aug 07, 2026 | 5.34 | 5.73 | 5.27 | 5.27 | 20821.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Target Group, Inc. (Canada) | 0.0011 |
| InMed Pharmaceuticals, Inc. | 1.305 |
| XORTX Therapeutics, Inc. | 2.08 |
| NervGen Pharma Corp. | 2.19 |
| Milestone Pharmaceuticals, Inc. | 0.9505 |
Price Related Metrics
| PS Ratio | 27.19 |
| Price to Book Value | 1.224 |
| Earnings Yield | -150.4% |
| Market Cap | 5.800M |